During the past decade, Zhejiang Provincial Peoples Hospital conducted 132 clinical trials. In the 10-year time frame, 132 clinical trials started and 9 clinical trials were completed, i.e. on average, 6.8% percent of trials that started reached the finish line to date. In the past 5 years, 104 clinical trials started and 9 clinical trials were completed. i.e. 8.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Zhejiang Provincial Peoples Hospital" #1 sponsor was "Zhejiang Provincial People's Hospital" with 9 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "Jiangsu HengRui Medicine Co., Ltd." with 6 trials sponsored, "Merck Sharp & Dohme LLC" with 6 trials sponsored and "Reistone Biopharma Company Limited" with 6 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 73 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Zhejiang Provincial Peoples Hospital" #1 collaborator was "Zhejiang Provincial People's Hospital" with 8 trials as a collaborator, "RenJi Hospital" with 4 trials as a collaborator, "Astellas Pharma Inc" with 3 trials as a collaborator, "First Affiliated Hospital of Guangxi Medical University" with 3 trials as a collaborator and "First Affiliated Hospital of Wenzhou Medical University" with 3 trials as a collaborator. Other collaborators include 194 different institutions and companies that were collaborators in the rest 133 trials.

According to Clinical.Site data, the most researched conditions in "Zhejiang Provincial Peoples Hospital" are "Prostatic Neoplasms" (5 trials), "Breast Cancer" (4 trials), "Advanced Solid Tumor" (3 trials), "Atopic Dermatitis" (3 trials) and "Hemorrhage" (3 trials). Many other conditions were trialed in "Zhejiang Provincial Peoples Hospital" in a lesser frequency.

Most popular intervention types in "Zhejiang Provincial Peoples Hospital" are "Drug" (106 trials), "Biological" (16 trials), "Other" (15 trials), "Device" (11 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "Pembrolizumab" (7 trials), "Cisplatin" (4 trials), "Docetaxel" (4 trials) and "Prednisone" (4 trials). Other intervention names were less common.

The vast majority of trials in "Zhejiang Provincial Peoples Hospital" are 122 trials for "All" genders, 16 trials for "Male" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Zhejiang Provincial Peoples Hospital". 4 are not yet recruiting, 58 are recruiting, 29 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 32 completed trials in Zhejiang Provincial Peoples Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Zhejiang Provincial Peoples Hospital, 12 "Phase 1" clinical trials were conducted, 38 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 15 trials that are defined as “Not Applicable".